Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for tubulin inhibitors (compound)
Most Correlated Studies
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
- Broad Connectivity Map (CMAP 2.0) compound database
- Drug target sets for approved compounds
- Liver Pharmacology and Xenobiotic Response Repertoire
Most Relevant Literature
- An update on the development on tubulin inhibitors for the treatment of solid tumors.
- Development of tubulin polymerization inhibitors as anticancer agents.
- Identification of Novel β-Tubulin Inhibitors Using a Combined In Silico/In Vitro Approach.
- The Potential Strategies for Overcoming Multidrug Resistance and Reducing Side Effects of Monomer Tu…
- Design, synthesis and bioevaluation of novel trifluoromethylquinoline derivatives as tubulin polymer…
Most Relevant Clinical Trials
- Safety,Tolerability and MTD KA2507 (HDAC6 Inhibitor) in Patients With Solid Tumours
- Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium …
- A Trial of ALB 109564(a) in Subjects With Advanced Solid Tumors
- Study of Tesetaxel in Japanese Patients With Solid Tumors
- Study of Eribulin in Children With Cancer to Determine Safety
